Biotech Values

[DewDiligence]

Acting Director of FDA’s CBER—>Scott Steele (scan to bottom of this post for Steele's bio):

Scott Steele, Ph.D. has been named FDA’s Acting Director for the Center for Biologics Evaluation and Research (CBER).

Dr. Steele is a science, technology, and policy professional at FDA with extensive experience in multiple disciplines, including emerging science and technology,…

— U.S. FDA (@US_FDA) April 1, 2025

Steele’s bio:
https://t.co/b3JqU1hzVn